NUKLEOTIDANALOGA
European patent · EP3036248 · In force
Register entry
- Publication number
- EP3036248
- Application number
- EP14837595
- Kind
- European patent with effect for Switzerland and Liechtenstein
- Status
- In force
- Specification
- Granted
- Filed
- Aug 19, 2014
- Published
- Jun 29, 2016
- Granted
- May 27, 2020
- Protection ends at the latest
- Aug 18, 2034
- Next annual fee due
- Aug 31, 2027
- IPC classes
- C07H 19/04 (2006.01)C07H 19/20 (2006.01)C07H 21/04 (2006.01)
- Priority
- US 201361867202 P 19.08.2013
- PCT application
- PCT/US2014/051726 19.08.2014
- PCT publication
- WO2015/026845 26.02.2015
- Filing language
- English
- Source
- Swissreg
History
What the Federal Institute of Intellectual Property published about this title, newest first.
- Sep 1, 2026
Next annual fee due on
- Next annual fee due on
- 31.08.2026 → 31.08.2027
Published in Swissreg on 01.09.2026
- Sep 1, 2025
Next annual fee due on
- Next annual fee due on
- 31.08.2025 → 31.08.2026
Published in Swissreg on 01.09.2025
- Sep 1, 2024
Next annual fee due on
- Next annual fee due on
- 31.08.2024 → 31.08.2025
Published in Swissreg on 01.09.2024
- Dec 20, 2023
Address changed
- Representative
- E. Blum & Co. AG, Patent- und Markenanwälte VSP, Vorderberg 11, 8044 Zürich → E. Blum & Co. AG, Hofwiesenstrasse 349, 8050 Zürich
Published in Swissreg on 20.12.2023
- Sep 1, 2023
Change
Published in Swissreg on 01.09.2023
- Sep 1, 2022
Change
Published in Swissreg on 01.09.2022
- May 29, 2020
Agent entered
- Representative
- E. Blum & Co. AG, Patent- und Markenanwälte VSP, Vorderberg 11, 8044 Zürich
Published in Swissreg on 29.05.2020
- May 27, 2020
Granted
Published in Swissreg on 27.05.2020
Parties
Inventor
Northbrook, Illinois 60062, US
The register names each party by name and address. A holder or agent is linked to an organization where exactly one entity of the commercial register bears its name; the street of a party not so recognised is not shown here.